Synonyms: ZE63-0302
Compound class:
Synthetic organic
Comment: The chemical structure for balomenib was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as a menin inhibitor with antineoplastic potential. An internet search aligns the INN with the clinical candidate ZE63-0302 (Eilean Therapeutics). ZE63-0302 is described as an oral inhibitor of the menin-KMT2A interaction, which is a validated anti-tumour mechanism. ZE63-0302 is designed to retain activity against menin inhibitor resistance mutations, and it also has more a favourable safety profile with regard to QTc prolongation and cardiotoxicity than preceeding menin inhibitors.
|
|
Bioactivity Comments |
We have been unable to uncover published quantitative data that supports ligand interaction with the compound's primary molecular target or its mechanism of action. |